ArticleScientific reports2025
Pulmonary function and motoric cognitive risk syndrome in older adults.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Poor pulmonary function (PF) has been linked to neurodegenerative disorders. However, the association of PF with motoric cognitive risk syndrome (MCR) which is a prodromal stage of dementia remains unclear. This study aimed to examine the PF-MCR association in older adults. In the English Longitudinal Study of Ageing (ELSA), the PF was quantified with forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), peak expiratory flow (PEF), and a composite PF (CPF) indicator. MCR was defined as the presence of subjective memory complaints and slow gait speed. Cox proportional hazards regression models were employed to examine PF-MCR associations. Among 3564 MCR-free participants at baseline, 421 developed an incident MCR over a median follow-up time of 10 (interquartile range [IQR], 4-14) years. In the multivariable analyses, compared with individuals with low CPF (tertile 1, reference), those with medium (tertile 2, hazard ratio [HR] = 0.79, 95% confidence intervals [CI] = 0.61 to 1.01, P = 0.061) and high levels (tertile 3, HR = 0.65, 95% CI = 0.47 to 0.89, P = 0.008) had decreased risks of incident MCR. Similar results were found when analyzing CPF in a continuous form (HR = 0.73, 95% CI = 0.62 to 0.85, P < 0.001). We also found significantly inverse associations of FVC, FEV1, and PEF with MCR risk. Our findings indicated that high PF is associated with decreased MCR risks. Early monitoring of PF and interventions for PF maintenance may assist in the prevention of MCR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.